Search Results 181-190 of 12349 for Multiple myeloma red flag
Investigation into new ways to improve the diagnosis and treatment of multiple myeloma continues at Mayo Clinic through laboratory investigations and clinical ...
In multiple myeloma, cancerous plasma cells accumulate in the bone marrow and crowd out healthy blood cells. Rather than produce helpful antibodies, the cancer ...
This phase II trial studies how well pembrolizumab, lenalidomide, and dexamethasone work in treating patients with newly diagnosed multiple myeloma that are ...
Study CRB-402 is a 2-part, non-randomized, open label, multi-site Phase 1 study of bb21217 in adults with relapsed/refractory multiple myeloma (MM).
... Multiple Myeloma. Participation eligibility ... Hemoglobin ≥ 8.0 g/dL; subject may receive red ... Subject must not have been treated with any systemic anti- ...
About this study. This phase II trial studies how well lenalidomide and dexamethasone work in treating patients with relapsed or refractory multiple myeloma ...
... myeloma published in the journal Cancer. Multiple Myeloma A complex cancer of the white blood cells, myeloma is rare. It affects about 100,000 people in the ...
Learn about this cancer that forms from white blood cells called plasma cells. Treatments include medicines and bone marrow transplant.
Founded Mayo Clinic's Myeloma, Amyloidosis and Dysproteinemia Clinic; Began collecting and recording data on all people with monoclonal plasma cell disorders.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Mayo Clinic researchers drive discoveries that improve detection, diagnosis and treatment. Your quick message to them means so much.